Nancy E. Dempze’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $251K | Sell |
2,950
-150
| -5% | -$13.4K | 0.14% | 82 |
|
|
2025
Q4 | $245K | Buy |
+3,100
| New | +$243K | 0.13% | 88 |
|
|
2025
Q3 | – | Sell |
-2,600
| Closed | -$236K | – | 89 |
|
|
2025
Q2 | $236K | Sell |
2,600
-75
| -3% | -$6.85K | 0.14% | 87 |
|
|
2025
Q1 | $251K | Sell |
2,675
-595
| -18% | -$53.3K | 0.15% | 86 |
|
|
2024
Q4 | $297K | Sell |
3,270
-180
| -5% | -$17.2K | 0.17% | 82 |
|
|
2024
Q3 | $358K | Sell |
3,450
-250
| -7% | -$25.5K | 0.2% | 81 |
|
|
2024
Q2 | $359K | Buy |
+3,700
| New | +$341K | 0.25% | 59 |
|
|
2022
Q1 | – | Sell |
-3,295
| Closed | -$281K | – | 79 |
|
|
2021
Q4 | $281K | Sell |
3,295
-54
| -2% | -$4.22K | 0.19% | 72 |
|
|
2021
Q3 | $253K | Hold |
3,349
| – | – | 0.2% | 70 |
|
|
2021
Q2 | $272K | Buy |
3,349
+119
| +4% | +$9.73K | 0.23% | 60 |
|
|
2021
Q1 | $254K | Hold |
3,230
| – | – | 0.22% | 63 |
|
|
2020
Q4 | $276K | Hold |
3,230
| – | – | 0.25% | 57 |
|
|
2020
Q3 | $249K | Hold |
3,230
| – | – | 0.25% | 56 |
|
|
2020
Q2 | $237K | Hold |
3,230
| – | – | 0.26% | 57 |
|
|
2020
Q1 | $214K | Sell |
3,230
-2,242
| -41% | -$158K | 0.29% | 56 |
|
|
2019
Q4 | $377K | Hold |
5,472
| – | – | 0.42% | 49 |
|
|
2019
Q3 | $403K | Hold |
5,472
| – | – | 0.49% | 44 |
|
|
2019
Q2 | $391K | Sell |
5,472
-700
| -11% | -$49.7K | 0.45% | 46 |
|
|
2019
Q1 | $423K | Hold |
6,172
| – | – | 0.5% | 45 |
|
|
2018
Q4 | $368K | Sell |
6,172
-702
| -10% | -$43.9K | 0.51% | 45 |
|
|
2018
Q3 | $461K | Sell |
6,874
-6
| -0.1% | -$400 | 0.52% | 45 |
|
|
2018
Q2 | $446K | Buy |
6,880
+1,110
| +19% | +$72.6K | 0.55% | 46 |
|
|
2018
Q1 | $414K | Sell |
5,770
-170
| -3% | -$12.2K | 0.51% | 48 |
|
|
2017
Q4 | $448K | Buy |
5,940
+400
| +7% | +$29.2K | 0.54% | 48 |
|
|
2017
Q3 | $403K | Buy |
5,540
+25
| +0.5% | +$1.8K | 0.57% | 48 |
|
|
2017
Q2 | $409K | Buy |
5,515
+525
| +11% | +$39K | 0.59% | 52 |
|
|
2017
Q1 | $364K | Hold |
4,990
| – | – | 0.56% | 54 |
|
|
2016
Q4 | $326K | Hold |
4,990
| – | – | 0.57% | 58 |
|
|
2016
Q3 | $370K | Hold |
4,990
| – | – | 0.65% | 50 |
|
|
2016
Q2 | $364K | Hold |
4,990
| – | – | 0.65% | 48 |
|
|
2016
Q1 | $352K | Buy |
4,990
+1,200
| +32% | +$79.8K | 0.62% | 55 |
|
|
2015
Q4 | $253K | Buy |
+3,790
| New | +$252K | 0.49% | 70 |
|
Other funds holding CL
VCM
DAM
VPM
Nancy E. Dempze's CL Position: Q1 2026 in Review
Nancy E. Dempze reduced its Colgate-Palmolive (CL) stake by 4.8% in Q1 2026, selling an estimated $13.4K and leaving 2,950 shares worth $251K. The position accounts for 0.14% of the portfolio, ranked #82.
Nancy E. Dempze first reported a position in CL in Q4 2015 and has held it in 32 quarters since. The position peaked at $461K in Q3 2018. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Nancy E. Dempze held 2,950 shares of Colgate-Palmolive worth $251K as of Q1 2026.
- Nancy E. Dempze sold 150 Colgate-Palmolive shares in Q1 2026, an estimated $13.4K.
- Colgate-Palmolive made up 0.14% of Nancy E. Dempze's portfolio in Q1 2026, its #82 holding.
- Nancy E. Dempze first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 32 quarters since.
- Nancy E. Dempze's Colgate-Palmolive position peaked at $461K in Q3 2018.
- 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Nancy E. Dempze's 13F filing for Q1 2026, filed 14 May 2026.